FOGHORN THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.99 USD | -1.96% |
|
+9.11% | -7.13% |
| 04-16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
| 04-16 | Foghorn Therapeutics Inc. Appoints Kristian Humer as Chief Financial Officer | CI |
Chart calendar Foghorn Therapeutics Inc.
ea.4SN7yzRE0yBmJX9WuY8yJaPmVdsPa5hbH7XQoMM07lc.jhc8rloKtHBWdREX7uJUdZuVP6lNAdliftuGxal5qSGVRwqpBzyLfzRVKg~3d5ab3c9d47f0cccee17bc57b3824892
Upcoming events on Foghorn Therapeutics Inc.
Past events on Foghorn Therapeutics Inc.
| 11/04/2024 16:45 | Needham Healthcare Conference |
| 10/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No:7185 / 26 |
| 09/04/2024 22:00 | Business Update Call |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster Number: 6067 / 26 |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No: 6064 / 23 |
| 09/04/2024 18:15 | American Association for Cancer Research Meeting - Symposium Session: SY12 |
| 09/04/2024 02:00 | American Association for Cancer Research Meeting - Symposium Session: TM04 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No: 3230 / 14 |
| 07/03/2024 12:00 | Q4 2023 Earnings Release |
| 04/03/2024 17:50 | TD Cowen Health Care Conference - Panel |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Publication Number: 4284 |
| 02/11/2023 17:30 | Connective Tissue Oncology Society Meeting - Mike Collins |
| 02/11/2023 16:00 | Connective Tissue Oncology Society Meeting - J. Andrew Livington |
| 02/11/2023 11:00 | Q3 2023 Earnings Release |
| 31/10/2023 18:30 | Targeted Protein Degradation Summit - Laura La Bonte |
| 31/10/2023 13:30 | Targeted Protein Degradation Summit - Steve Bellon |
| 21/10/2023 | European Society for Medical Oncology Congress |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster Number: C016 |
| 13/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster Number: B002 |
| 12/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster Number: A041 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,43 0,69 -37.32% | 1,32 0,77 71.97% | 19,2 22,9 -16.11% | 34,2 32,4 5.27% | 35,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -67,2 -58,7 -14.46% | -97,5 -67,1 -45.38% | -114 -111 -2.46% | -104 -109 4.19% | -123 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -68,5 -62,5 -9.67% | -101 -87,8 -14.72% | -117 -112 -4.43% | -108 -115 6.42% | -209 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -68,8 -65,2 -5.59% | -101 -99,8 -1.5% | -109 -107 -1.99% | -94,2 -105 10.02% | -317 |
|
Net income Million USD | Released Forecast Spread | -51,1 | -68,8 -65,2 -5.59% | -101 -99,6 -1.72% | -109 -107 -1.69% | -98,4 -105 6.12% | -247 |
|
EPS USD | Released Forecast Spread | -1,41 | -6,23 -4,99 -24.93% | -2,73 -2,68 -1.87% | -2,62 -2,55 -2.64% | -2,34 -2,49 6.12% | -4,04 |
| Announcement Date | 02/10/20 | 18/03/21 | 10/03/22 | 09/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,71 0,22 229.07% | 3,92 11,3 -65.21% | 4,49 8,69 -48.32% | 6,63 9,58 -30.78% | 4,18 10,6 -60.52% | 5,31 5,04 5.39% | 5,60 6,26 -10.6% | 17,5 5,65 209.28% | 5,77 5,78 -0.13% | 7,35 | 7,45 | 8,56 | 8,67 | 15,0 |
|
EBIT Million USD | Released Forecast Spread | -28,1 -27,5 -2.03% | -27,8 -24,4 -13.87% | -29,2 -23,2 -25.95% | -28,3 -25,6 -10.25% | -31,9 -28,9 -10.26% | -33,3 -34,9 4.55% | -32,1 -33,2 3.6% | -17,1 -34,1 49.97% | -25,5 -33,0 22.74% | -30,9 | -31,7 | -30,5 | -31,9 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,1 -27,7 -5.17% | -26,9 -20,1 -33.9% | -27,3 -13,6 -100.55% | -25,8 -17,4 -48.16% | -28,9 -23,2 -24.34% | -29,9 -28,6 -4.57% | -28,5 -30,8 7.29% | -13,6 -30,2 54.91% | -22,1 -30,5 27.53% | -24,2 | -25,4 | -20,8 | -27,2 | |
|
Net income Million USD | Released Forecast Spread | -29,1 -27,4 -6.37% | -26,9 -20,3 -32.89% | -27,3 -19,6 -39.64% | -25,8 -22,7 -13.48% | -28,9 -24,8 -16.33% | -30,5 -30,2 -0.91% | -29,5 -31,8 7.29% | -14,3 -30,4 52.78% | -24,1 -29,2 17.42% | -24,6 | -25,9 | -27,3 | -28,7 | |
|
EPS USD | Released Forecast Spread | -0,77 -0,74 -4.76% | -0,65 -0,43 -52.34% | -0,66 -0,59 -12.34% | -0,62 -0,59 -4.49% | -0,69 -0,62 -10.84% | -0,73 -0,77 4.89% | -0,70 -0,74 4.76% | -0,34 -0,75 54.67% | -0,57 -0,72 20.83% | -1,74 | -1,78 | -1,00 | -1,02 | |
| Announcement Date | 10/03/22 | 09/05/22 | 09/08/22 | 08/11/22 | 09/03/23 | 08/05/23 | 04/08/23 | 02/11/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for Foghorn Therapeutics Inc.
| 03/05/2024 12:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FHTX Stock
- Calendar Foghorn Therapeutics Inc.
